[{"NetIncomeLoss_1_Q3_USD":-9985000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":200081000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":437516000.0,"AssetsCurrent_0_Q3_USD":742259000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":5522000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":5000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":757000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":289000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":68512000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q3_USD":2441000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":956000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":49000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":55455000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":44473000.0,"PaymentsForHedgeFinancingActivities_3_Q3_USD":52390000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":34356936.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-277757000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":33398454.0,"StandardProductWarrantyAccrualPayments_3_Q3_USD":1596000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":80443000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CashUninsuredAmount_0_Q3_USD":6000000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":19012000.0,"ShareBasedCompensation_3_Q3_USD":32537000.0,"Assets_0_Q3_USD":778444000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":498515000.0,"StandardProductWarrantyAccrualPayments_1_Q3_USD":628000.0,"CommonStockSharesIssued_0_Q3_shares":34419299.0,"ForeignCurrencyTransactionGainLossRealized_1_Q3_USD":128000.0,"ForeignCurrencyTransactionGainLossRealized_3_Q3_USD":-406000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":5258000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":3202000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":9222447.0,"LossContingencyAccrualAtCarryingValue_0_Q3_USD":0.0,"CostOfGoodsAndServicesSold_1_Q3_USD":32383000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":155646000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q3_USD":55905000.0,"MoneyMarketFundsAtCarryingValue_0_Q3_USD":50700000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"InterestPayableCurrent_0_Q3_USD":3534000.0,"IncomeTaxExaminationPenaltiesAndInterestExpense_1_Q3_USD":0.0,"IncomeTaxExaminationPenaltiesAndInterestExpense_3_Q3_USD":0.0,"CommonStockValue_0_Q3_USD":35000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":208000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":558000.0,"AccountsReceivableNetCurrent_0_Q3_USD":78722000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q3_USD":55924000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-402000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":-6516000.0,"InventoryWriteDown_3_Q3_USD":4216000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-152000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":73000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":25187000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":11114000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":33770000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-645000.0,"ProvisionForDoubtfulAccounts_3_Q3_USD":2395000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":3654000.0,"ForeignCurrencyTransactionGainLossUnrealized_3_Q3_USD":264000.0,"OperatingLeaseLiability_0_Q3_USD":21448000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":-2654000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":33613000.0,"Liabilities_0_Q3_USD":398664000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":865400000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":17670000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":118628000.0,"DepreciationDepletionAndAmortization_1_Q3_USD":1174000.0,"OtherAssetsNoncurrent_0_Q3_USD":3983000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-9380000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-75574000.0,"IncreaseDecreaseInInventories_3_Q3_USD":-3237000.0,"StandardProductWarrantyAccrualCurrent_0_Q3_USD":991000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":341766000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q3_USD":442329000.0,"ForeignCurrencyTransactionGainLossUnrealized_1_Q3_USD":-493000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":8716000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":3739000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":5688000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-3315000.0,"InterestExpense_1_Q3_USD":6363000.0,"InterestExpense_3_Q3_USD":15311000.0,"AccountsPayableCurrent_0_Q3_USD":24473000.0,"LiabilitiesCurrent_0_Q3_USD":239431000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":5073000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q3_USD":442591000.0,"GainLossOnDispositionOfAssets1_3_Q3_USD":-12000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":6517000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":28694000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":13971000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":5179000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-9777000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-75378000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":286000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":605000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":362000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-10668000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":16632000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_Q3_USD":-86000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_1_Q3_USD":200000.0,"NetIncomeLoss_3_Q3_USD":-75936000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":12234000.0,"ShortTermBorrowings_0_Q3_USD":166608000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":1032000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"OperatingLeasePayments_1_Q3_USD":1247000.0,"OperatingLeasePayments_3_Q3_USD":3676000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_3_Q3_USD":2500000.0,"NumberOfOperatingSegments_3_Q3_Business":1.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":-1858000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.07,"GrossProfit_1_Q3_USD":76077000.0,"GrossProfit_3_Q3_USD":171874000.0,"AccruedIncomeTaxesCurrent_0_Q3_USD":1061000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":5587000.0,"LongTermDebtNoncurrent_0_Q3_USD":139504000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":119584000.0,"CommonStockSharesOutstanding_0_Q3_shares":34419299.0,"ProceedsFromConvertibleDebt_3_Q3_USD":189750000.0,"AssetImpairmentCharges_3_Q3_USD":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":30111000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":778444000.0,"OperatingLeaseCost_1_Q3_USD":1234000.0,"OperatingLeaseCost_3_Q3_USD":3702000.0,"PreferredStockValue_0_Q3_USD":null,"InvestmentIncomeInterest_1_Q3_USD":537000.0,"ProceedsFromIssuanceOfWarrants_3_Q3_USD":34933000.0,"InvestmentIncomeInterest_3_Q3_USD":2555000.0,"InventoryNet_0_Q3_USD":84149000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":454243000.0,"OperatingIncomeLoss_1_Q3_USD":-3549000.0,"OperatingIncomeLoss_3_Q3_USD":-61977000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":108460000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":252317000.0,"CommonStockSharesAuthorized_0_Q3_shares":290000000.0,"ProceedsFromIssuanceInitialPublicOffering_3_Q3_USD":147144000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":28866000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":3778000.0,"OperatingExpenses_3_Q3_USD":233851000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-1459000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":53255000.0,"StandardProductWarrantyAccrualWarrantiesIssued_1_Q3_USD":686000.0,"StandardProductWarrantyAccrualWarrantiesIssued_3_Q3_USD":1409000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-485704000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":10510000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-130000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":498234000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q3_USD":3207000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":3387000.0,"StockholdersEquity_0_Q3_USD":379780000.0,"OtherLiabilitiesCurrent_0_Q3_USD":3877000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":2059000.0,"ProfitLoss_3_Q3_USD":-75936000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.29,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-2.27,"OperatingExpenses_1_Q3_USD":79626000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":1247000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":2275000.0,"Ticker":"NVRO","CIK":"1444380","name":"NEVRO CORP","OfficialName":"Nevro Corp. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2648227724.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NYSE","SP500":"nan","filed":"20201105"}]